Day traders and active traders have many movers this Wednesday morning to choose from.  The top alerts were seen in Symantec Corporation (NASDAQ: SYMC), Check Point Software Technologies Ltd. (NASDAQ: CHKP), Brocade Communications Systems, Inc. (NASDAQ: BRCD), BSD Medical Corporation (NASDAQ: BSDM), MannKind Corporation (NASDAQ: MNKD), NetApp Inc. (NASDAQ: NTAP), PetSmart, Inc. (NASDAQ: PETM), and StemCells Inc. (NASDAQ: STEM).

The Intel-McAfee deal already has the primary move taken care of, but the data-security peers are the ones to watch.  Symantec Corporation (NASDAQ: SYMC) is a very troubled company with data security and storage, and its shares are now up 12% at $14.18 in the pre-market trading.  Check Point Software Technologies Ltd. (NASDAQ: CHKP) is also up 5.4% at $36.14 in pre-market trading.

Brocade Communications Systems, Inc. (NASDAQ: BRCD) is getting squeezed this morning and shares are down 6.8% at $4.79 on more than 600,000 shares.  This is worse than last night when Brocade went out in the after-hours session down 4.67% at $4.90 on 874,644 shares.

BSD Medical Corporation (NASDAQ: BSDM) is seeing a second day win after yesterday’s news of an FDA Approval that sent shares up about 100%. Shares are up another 6% at $3.15 on over 400,000 shares.

MannKind Corporation (NASDAQ: MNKD) is trading up almost 4% at $6.20 on about 200,000 shares after pricing $100 million in senior convertible notes amd entering into a share sale and share lending agreement.  The secondary sale was at $5.55 versus a close of $5.97 yesterday.

NetApp Inc. (NASDAQ: NTAP) is down 3.1% this morning from $39.32 to $38.09 in pre-market trading on active volume after earnings disappointed.

PetSmart, Inc. (NASDAQ: PETM) is trading up after earnings and strong guidance and after Goldman maintained a neutral rating but raised the price target. Shares are seeing thin volume but the first indication was up almost 7% at $32.23.  This one went out in the after-hours session last night up 7.2% at $32.33 on 144,000 shares.

StemCells Inc. (NASDAQ: STEM) is on the move after positive stem cell data in paralysis.  Shares are up 24% at $1.08 on over 550,000 shares.  Average volume is only 723,000 shares and a 52-week range of $0.84 to $1.79.

You can join our free daily email distribution list to hear more about dividend trends, analyst upgrades and downgrades, top day trader and active trader alerts, news on Buffett and other investment gurus, IPOs, secondary offerings, private equity, and more.

JON C. OGG

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.